View Printer-Friendly PDF

A Drug Development & Outsourcing Profile

Akshaya Bio Inc.

Compass Place
904-10050 - 112 Street NW
Edmonton AB  T5K 2J1  Canada

  • Tel: 780-493-1706
  • Mgmt: Dr. Rajan George
  • Mktg: Rohit George
  • R&D: Dr. Rajan George
  • Licng: Dr. Rajan George
  • Est: 2010 - Private
  • Rev: $5–10 M
  • Staff: 1–10
  • Recombinants
  • Research & Dev.
  • Biologics
  • Chronic Disease
  • Immunology
  • Immunotherapy
  • Infectious Diseases
  • Influenza
  • Therapeutics-Protein
  • Vaccines

Akshaya Bio is a privately held development stage biotechnology company located in Edmonton, Alberta, Canada. Akshaya develops innovative therapeutics for infectious diseases & cancer. Akshaya's proprietary Chimigen® Platform Technology which uses dendritic cell receptor-targeted chimeric molecules to develop a portfolio of biotherapeutic agents to meet major unmet needs such as treatments for HBV & HCV, HIV, Malaria, influenza, COVID-19 & cancer. Lead product candidate is Chimigen® HBV, for chronic hepatitis B.

Mfg: No   Labs: No

0.0038